Harvard’s immune-silent stem cell technique licensed to Sana Biotechnology
Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”
Caroline Perry
• harvard
March 26, 2019 • ~6 min
March 26, 2019 • ~6 min
/
1